Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $306.04 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $147.35 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $103.36 | 1 | $0 (2018) |
| Allergan Inc. | $55.33 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $35.25 | 1 | Janssen Pharmaceuticals, Inc ($35.25) |
| 2022 | $79.67 | 3 | Janssen Pharmaceuticals, Inc ($79.67) |
| 2021 | $32.43 | 1 | Janssen Pharmaceuticals, Inc ($32.43) |
| 2019 | $18.28 | 1 | Allergan Inc. ($18.28) |
| 2018 | $118.99 | 2 | Novartis Pharmaceuticals Corporation ($103.36) |
| 2017 | $21.42 | 1 | Allergan Inc. ($21.42) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/20/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $103.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ANTI-INFECTIVE | ||||||
About Arun Raman, M.B.,B.S
Arun Raman, M.B.,B.S is a Surgery healthcare provider based in Lincoln City, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376756700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arun Raman, M.B.,B.S has received a total of $306.04 in payments from pharmaceutical and medical device companies, with $35.25 received in 2023. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($306.04).
Practice Information
- Specialty Surgery
- Location Lincoln City, OR
- Active Since 05/08/2007
- Last Updated 03/05/2013
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1376756700
Products in Payments
- XARELTO (Drug) $147.35
- ENTRESTO (Drug) $103.36
- AVYCAZ (Drug) $37.05
- TEFLARO (Drug) $18.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.